These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30240355)

  • 1. Analyzing the capability of PSP, PCT and sCD25 to support the diagnosis of infection in cancer patients with febrile neutropenia.
    García de Guadiana-Romualdo L; Jiménez-Santos E; Cerezuela-Fuentes P; Español-Morales I; Berger M; Esteban-Torrella P; Hernando-Holgado A; Albaladejo-Otón MD
    Clin Chem Lab Med; 2019 Mar; 57(4):540-548. PubMed ID: 30240355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic stone protein and soluble CD25 for infection and sepsis in an emergency department.
    García de Guadiana-Romualdo L; Berger M; Jiménez-Santos E; Rebollo-Acebes S; Jiménez-Sánchez R; Esteban-Torrella P; Hernando-Holgado A; Ortín-Freire A; Albaladejo-Otón MD
    Eur J Clin Invest; 2017 Apr; 47(4):297-304. PubMed ID: 28155994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis biomarkers in unselected patients on admission to intensive or high-dependency care.
    Llewelyn MJ; Berger M; Gregory M; Ramaiah R; Taylor AL; Curdt I; Lajaunias F; Graf R; Blincko SJ; Drage S; Cohen J
    Crit Care; 2013 Mar; 17(2):R60. PubMed ID: 23531337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.
    García de Guadiana-Romualdo L; Español-Morales I; Cerezuela-Fuentes P; Consuegra-Sánchez L; Hernando-Holgado A; Esteban-Torrella P; Jiménez-Santos E; Viqueira-González M; de Béjar-Almira Á; Albaladejo-Otón MD
    Support Care Cancer; 2015 Jul; 23(7):2175-82. PubMed ID: 25564222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin and Interleukin-10 May Assist in Early Prediction of Bacteraemia in Children With Cancer and Febrile Neutropenia.
    Doerflinger M; Haeusler GM; Li-Wai-Suen CSN; Clark JE; Slavin M; Babl FE; Allaway Z; Mechinaud F; Smyth GK; De Abreu Lourenco R; Phillips B; Pellegrini M; Thursky KA
    Front Immunol; 2021; 12():641879. PubMed ID: 34093531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of procalcitonin and lipopolysaccharide binding protein in cancer patients with chemotherapy-associated febrile neutropenia presenting to an emergency department.
    García de Guadiana-Romualdo L; Cerezuela-Fuentes P; Español-Morales I; Esteban-Torrella P; Jiménez-Santos E; Hernando-Holgado A; Albaladejo-Otón MD
    Biochem Med (Zagreb); 2019 Feb; 29(1):010702. PubMed ID: 30591812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin versus C-Reactive Protein as a Biomarker for Prediction of Bacterial Infection in Children with Febrile Neutropenia in Acute Leukemia.
    Nahar A; Jamal CY; Refat R; Chowdhury T; Akter S; Karim A; Rahman MA; Yeamin MB; Saha BK; Hossain F; Rabbany MA
    Mymensingh Med J; 2023 Jan; 32(1):76-82. PubMed ID: 36594305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.
    Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M
    Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment value of interleukin-6, procalcitonin, and C-reactive protein early kinetics for initial antibiotic efficacy in patients with febrile neutropenia: A prospective study.
    Zheng H; Luo Z; Yi Y; Liu K; Huo Z; You Y; Li H; Tang M
    Cancer Med; 2024 Jul; 13(13):e7307. PubMed ID: 38967137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and prognostic value of angiopoietins compared with C-reactive protein and procalcitonin in children with febrile neutropenia.
    Mimaroğlu E; Çıtak EÇ; Kuyucu N; Eskendari G
    Turk J Pediatr; 2017; 59(4):418-425. PubMed ID: 29624222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India.
    Halder R; Seth T; Chaturvedi PK; Mishra P; Mahapatra M; Pati HP; Tyagi S; Saxena R
    Blood Cells Mol Dis; 2020 Sep; 84():102445. PubMed ID: 32480243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients.
    Moustafa R; Albouni T; Aziz G
    PLoS One; 2021; 16(7):e0253842. PubMed ID: 34324506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: A useful alternative to the multinational association for supportive care in cancer score.
    Chaftari P; Chaftari AM; Hachem R; Yeung SJ; Dagher H; Jiang Y; Malek AE; Dailey Garnes N; Mulanovich VE; Raad I
    Cancer Med; 2021 Dec; 10(23):8475-8482. PubMed ID: 34725958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer.
    Srinivasan A; Kumar N; Scott JX
    Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serial measurement of pancreatic stone protein for the early detection of sepsis in intensive care unit patients: a prospective multicentric study.
    Pugin J; Daix T; Pagani JL; Morri D; Giacomucci A; Dequin PF; Guitton C; Que YA; Zani G; Brealey D; Lepape A; Creagh-Brown B; Wyncoll D; Silengo D; Irincheeva I; Girard L; Rebeaud F; Maerki I; Eggimann P; François B
    Crit Care; 2021 Apr; 25(1):151. PubMed ID: 33879189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective cohort study of procalcitonin levels in children with cancer presenting with febrile neutropenia.
    Hemming V; Jakes AD; Shenton G; Phillips B
    BMC Pediatr; 2017 Jan; 17(1):2. PubMed ID: 28056911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and diagnostic utility of pancreatic stone protein in pediatric sepsis and mortality.
    Dündar MA; Ceran E; Akyildiz BN
    Turk J Med Sci; 2024; 54(4):744-751. PubMed ID: 39295616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive value of procalcitonin, C-reactive protein, presepsin, and soluble-triggering receptor expressed on myeloid cell levels in bloodstream infections in pediatric patients with febrile neutropenia.
    Özdemir ZC; Düzenli-Kar Y; Canik A; Küskü-Kiraz Z; Özen H; Bör Ö
    Turk J Pediatr; 2019; 61(3):359-367. PubMed ID: 31916713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Serum Procalcitonin Levels in Patients With Febrile Neutropenia Presenting to the Emergency Department.
    Yadav S; Mathew R; Sahu AK; Jamshed N; Mohindra R; Aggarwal P; Batra A; Halder D; Brunda RL
    J Emerg Med; 2021 May; 60(5):641-647. PubMed ID: 33518374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
    van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
    Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.